The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Drug for Therapeutic Market Research Report 2025
Synopsis
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
The global Nuclear Drug for Therapeutic market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nuclear Drug for Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Drug for Therapeutic.
Report Scope
The Nuclear Drug for Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Drug for Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Drug for Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Drug for Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
The global Nuclear Drug for Therapeutic market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nuclear Drug for Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Drug for Therapeutic.
Report Scope
The Nuclear Drug for Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Drug for Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Drug for Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Drug for Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nuclear Drug for Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Drug for Therapeutic Market Perspective (2019-2030)
2.2 Nuclear Drug for Therapeutic Growth Trends by Region
2.2.1 Global Nuclear Drug for Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nuclear Drug for Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Nuclear Drug for Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Nuclear Drug for Therapeutic Market Dynamics
2.3.1 Nuclear Drug for Therapeutic Industry Trends
2.3.2 Nuclear Drug for Therapeutic Market Drivers
2.3.3 Nuclear Drug for Therapeutic Market Challenges
2.3.4 Nuclear Drug for Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Drug for Therapeutic Players by Revenue
3.1.1 Global Top Nuclear Drug for Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Drug for Therapeutic Revenue
3.4 Global Nuclear Drug for Therapeutic Market Concentration Ratio
3.4.1 Global Nuclear Drug for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Drug for Therapeutic Revenue in 2023
3.5 Nuclear Drug for Therapeutic Key Players Head office and Area Served
3.6 Key Players Nuclear Drug for Therapeutic Product Solution and Service
3.7 Date of Enter into Nuclear Drug for Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Drug for Therapeutic Breakdown Data by Type
4.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2025-2030)
5 Nuclear Drug for Therapeutic Breakdown Data by Application
5.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nuclear Drug for Therapeutic Market Size (2019-2030)
6.2 North America Nuclear Drug for Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nuclear Drug for Therapeutic Market Size by Country (2019-2024)
6.4 North America Nuclear Drug for Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Drug for Therapeutic Market Size (2019-2030)
7.2 Europe Nuclear Drug for Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nuclear Drug for Therapeutic Market Size by Country (2019-2024)
7.4 Europe Nuclear Drug for Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Nuclear Drug for Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Drug for Therapeutic Market Size (2019-2030)
9.2 Latin America Nuclear Drug for Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nuclear Drug for Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Nuclear Drug for Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Nuclear Drug for Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Nuclear Drug for Therapeutic Introduction
11.1.4 Bayer Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Nuclear Drug for Therapeutic Introduction
11.2.4 Novartis Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Detail
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Introduction
11.3.4 China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Detail
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Nuclear Drug for Therapeutic Introduction
11.4.4 Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Detail
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Nuclear Drug for Therapeutic Introduction
11.5.4 Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Detail
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Introduction
11.6.4 Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Detail
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Introduction
11.7.4 Jubilant Radiopharma Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.7.5 Jubilant Radiopharma Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Detail
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Nuclear Drug for Therapeutic Introduction
11.8.4 Lantheus Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.8.5 Lantheus Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Detail
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Introduction
11.9.4 Aurobindo Pharma Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.9.5 Aurobindo Pharma Recent Development
11.10 International Isotopes
11.10.1 International Isotopes Company Detail
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Nuclear Drug for Therapeutic Introduction
11.10.4 International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.10.5 International Isotopes Recent Development
11.11 Mundipharma
11.11.1 Mundipharma Company Detail
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Nuclear Drug for Therapeutic Introduction
11.11.4 Mundipharma Revenue in Nuclear Drug for Therapeutic Business (2019-2024)
11.11.5 Mundipharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Nuclear Drug for Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Nuclear Drug for Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Nuclear Drug for Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Nuclear Drug for Therapeutic Market Share by Region (2019-2024)
Table 10. Global Nuclear Drug for Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Nuclear Drug for Therapeutic Market Share by Region (2025-2030)
Table 12. Nuclear Drug for Therapeutic Market Trends
Table 13. Nuclear Drug for Therapeutic Market Drivers
Table 14. Nuclear Drug for Therapeutic Market Challenges
Table 15. Nuclear Drug for Therapeutic Market Restraints
Table 16. Global Nuclear Drug for Therapeutic Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Nuclear Drug for Therapeutic Market Share by Players (2019-2024)
Table 18. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2023)
Table 19. Ranking of Global Top Nuclear Drug for Therapeutic Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Nuclear Drug for Therapeutic Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nuclear Drug for Therapeutic Product Solution and Service
Table 23. Date of Enter into Nuclear Drug for Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nuclear Drug for Therapeutic Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2019-2024)
Table 27. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2025-2030)
Table 29. Global Nuclear Drug for Therapeutic Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2019-2024)
Table 31. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2025-2030)
Table 33. North America Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Nuclear Drug for Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Nuclear Drug for Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Nuclear Drug for Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Nuclear Drug for Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Nuclear Drug for Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Nuclear Drug for Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nuclear Drug for Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bayer Company Detail
Table 49. Bayer Business Overview
Table 50. Bayer Nuclear Drug for Therapeutic Product
Table 51. Bayer Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 52. Bayer Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Nuclear Drug for Therapeutic Product
Table 56. Novartis Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. China Isotope & Radiation Company Detail
Table 59. China Isotope & Radiation Business Overview
Table 60. China Isotope & Radiation Nuclear Drug for Therapeutic Product
Table 61. China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 62. China Isotope & Radiation Recent Development
Table 63. Dongcheng Company Detail
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Nuclear Drug for Therapeutic Product
Table 66. Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 67. Dongcheng Recent Development
Table 68. Q BioMed Company Detail
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Nuclear Drug for Therapeutic Product
Table 71. Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 72. Q BioMed Recent Development
Table 73. Curium Pharmaceuticals Company Detail
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product
Table 76. Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 77. Curium Pharmaceuticals Recent Development
Table 78. Jubilant Radiopharma Company Detail
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Nuclear Drug for Therapeutic Product
Table 81. Jubilant Radiopharma Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 82. Jubilant Radiopharma Recent Development
Table 83. Lantheus Company Detail
Table 84. Lantheus Business Overview
Table 85. Lantheus Nuclear Drug for Therapeutic Product
Table 86. Lantheus Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 87. Lantheus Recent Development
Table 88. Aurobindo Pharma Company Detail
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Nuclear Drug for Therapeutic Product
Table 91. Aurobindo Pharma Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 92. Aurobindo Pharma Recent Development
Table 93. International Isotopes Company Detail
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Nuclear Drug for Therapeutic Product
Table 96. International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 97. International Isotopes Recent Development
Table 98. Mundipharma Company Detail
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Nuclear Drug for Therapeutic Product
Table 101. Mundipharma Revenue in Nuclear Drug for Therapeutic Business (2019-2024) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Drug for Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nuclear Drug for Therapeutic Market Share by Type: 2023 VS 2030
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Nuclear Drug for Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Nuclear Drug for Therapeutic Market Share by Application: 2023 VS 2030
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Nuclear Drug for Therapeutic Report Years Considered
Figure 14. Global Nuclear Drug for Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Nuclear Drug for Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Nuclear Drug for Therapeutic Market Share by Region: 2023 VS 2030
Figure 17. Global Nuclear Drug for Therapeutic Market Share by Players in 2023
Figure 18. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Nuclear Drug for Therapeutic Revenue in 2023
Figure 20. North America Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Nuclear Drug for Therapeutic Market Share by Country (2019-2030)
Figure 22. United States Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Nuclear Drug for Therapeutic Market Share by Country (2019-2030)
Figure 26. Germany Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2019-2030)
Figure 34. China Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Nuclear Drug for Therapeutic Market Share by Country (2019-2030)
Figure 42. Mexico Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Country (2019-2030)
Figure 46. Turkey Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Nuclear Drug for Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 50. China Isotope & Radiation Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 51. Dongcheng Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 52. Q BioMed Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 53. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 54. Jubilant Radiopharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 55. Lantheus Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 56. Aurobindo Pharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 57. International Isotopes Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 58. Mundipharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
